1. Home
  2. STXS vs TEAF Comparison

STXS vs TEAF Comparison

Compare STXS & TEAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STXS
  • TEAF
  • Stock Information
  • Founded
  • STXS 1990
  • TEAF 2017
  • Country
  • STXS United States
  • TEAF United States
  • Employees
  • STXS N/A
  • TEAF N/A
  • Industry
  • STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • TEAF Trusts Except Educational Religious and Charitable
  • Sector
  • STXS Health Care
  • TEAF Finance
  • Exchange
  • STXS Nasdaq
  • TEAF Nasdaq
  • Market Cap
  • STXS 151.3M
  • TEAF 163.0M
  • IPO Year
  • STXS 2004
  • TEAF N/A
  • Fundamental
  • Price
  • STXS $2.26
  • TEAF $12.10
  • Analyst Decision
  • STXS
  • TEAF
  • Analyst Count
  • STXS 0
  • TEAF 0
  • Target Price
  • STXS N/A
  • TEAF N/A
  • AVG Volume (30 Days)
  • STXS 276.5K
  • TEAF 56.1K
  • Earning Date
  • STXS 08-11-2025
  • TEAF 01-01-0001
  • Dividend Yield
  • STXS N/A
  • TEAF 9.20%
  • EPS Growth
  • STXS N/A
  • TEAF N/A
  • EPS
  • STXS N/A
  • TEAF N/A
  • Revenue
  • STXS $27,510,000.00
  • TEAF N/A
  • Revenue This Year
  • STXS $25.90
  • TEAF N/A
  • Revenue Next Year
  • STXS $60.57
  • TEAF N/A
  • P/E Ratio
  • STXS N/A
  • TEAF N/A
  • Revenue Growth
  • STXS 1.50
  • TEAF N/A
  • 52 Week Low
  • STXS $1.54
  • TEAF $11.11
  • 52 Week High
  • STXS $2.72
  • TEAF $13.30
  • Technical
  • Relative Strength Index (RSI)
  • STXS 55.31
  • TEAF 61.83
  • Support Level
  • STXS $2.12
  • TEAF $12.10
  • Resistance Level
  • STXS $2.32
  • TEAF $12.22
  • Average True Range (ATR)
  • STXS 0.10
  • TEAF 0.11
  • MACD
  • STXS 0.01
  • TEAF -0.01
  • Stochastic Oscillator
  • STXS 70.00
  • TEAF 72.66

About STXS Stereotaxis Inc.

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.

About TEAF Ecofin Sustainable and Social Impact Term Fund

Tortoise Essential Assets Income Term is a USA-based non-diversified, closed-end management investment company. Its investment objective is to provide common shareholders with a high level of total return with an emphasis on current distributions.

Share on Social Networks: